Royalty Pharma plc
RPRX
Ранг среди акций
#894
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Цена акции
$60.39
Последняя синхронизация: 2026-10-19
Рыночная капитализация
$26.89B
Изменение (1 день)
-0.93%
Изменение (1 год)
64.87%
Страна
US
Торговля Royalty Pharma plc (RPRX)
Категория
Healthcare
EPS для Royalty Pharma plc (RPRX)
EPS по состоянию на June 2026 TTM: $2.41
Согласно последним финансовым отчетам и цене акций Royalty Pharma plc, текущий EPS компании (TTM) составляет $2.41. В конце 2024 EPS компании составлял $1.92, меньше, чем показателю 2023 года, равному $2.54.
История EPS компании Royalty Pharma plc с 2015 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| 2026 (TTM) | $2.41 | 34.64% |
| 2025 | $1.79 | -6.61% |
| 2024 | $1.92 | -24.41% |
| 2023 | $2.54 | 2,492.43% |
| 2022 | $0.10 | -93.45% |
| 2021 | $1.49 | -42.47% |
| 2020 | $2.60 | -59.54% |
| 2019 | $6.42 | 182.80% |
| 2018 | $2.27 | 13.86% |
| 2017 | $1.99 | 113.83% |
| 2016 | $0.93 | -2.67% |
| 2015 | $0.96 | 0.00% |
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $0.52 | -78.42% |
US
|
|
| $0.02 | -99.22% |
HK
|
